• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

论边缘混杂因素患病率的作用——对高维倾向评分算法的影响

On the role of marginal confounder prevalence - implications for the high-dimensional propensity score algorithm.

作者信息

Schuster Tibor, Pang Menglan, Platt Robert W

机构信息

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.

Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.

出版信息

Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):1004-7. doi: 10.1002/pds.3773. Epub 2015 Apr 10.

DOI:10.1002/pds.3773
PMID:25866189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5072887/
Abstract

PURPOSE

The high-dimensional propensity score algorithm attempts to improve control of confounding in typical treatment effect studies in pharmacoepidemiology and is increasingly being used for the analysis of large administrative databases. Within this multi-step variable selection algorithm, the marginal prevalence of non-zero covariate values is considered to be an indicator for a count variable's potential confounding impact. We investigate the role of the marginal prevalence of confounder variables on potentially caused bias magnitudes when estimating risk ratios in point exposure studies with binary outcomes.

METHODS

We apply the law of total probability in conjunction with an established bias formula to derive and illustrate relative bias boundaries with respect to marginal confounder prevalence.

RESULTS

We show that maximum possible bias magnitudes can occur at any marginal prevalence level of a binary confounder variable. In particular, we demonstrate that, in case of rare or very common exposures, low and high prevalent confounder variables can still have large confounding impact on estimated risk ratios.

CONCLUSIONS

Covariate pre-selection by prevalence may lead to sub-optimal confounder sampling within the high-dimensional propensity score algorithm. While we believe that the high-dimensional propensity score has important benefits in large-scale pharmacoepidemiologic studies, we recommend omitting the prevalence-based empirical identification of candidate covariates.

摘要

目的

高维倾向评分算法试图在药物流行病学的典型治疗效果研究中改善混杂因素的控制,并且越来越多地用于大型管理数据库的分析。在这个多步骤变量选择算法中,非零协变量值的边际患病率被视为计数变量潜在混杂影响的一个指标。我们研究了在二元结局的点暴露研究中估计风险比时,混杂变量的边际患病率对潜在导致的偏倚大小的作用。

方法

我们应用全概率定律结合一个既定的偏倚公式来推导和说明关于边际混杂因素患病率的相对偏倚界限。

结果

我们表明,二元混杂变量的任何边际患病率水平都可能出现最大可能的偏倚大小。特别是,我们证明,在暴露罕见或非常常见的情况下,低患病率和高患病率的混杂变量仍可能对估计的风险比产生很大的混杂影响。

结论

在高维倾向评分算法中,按患病率进行协变量预选择可能导致混杂因素抽样次优。虽然我们认为高维倾向评分在大规模药物流行病学研究中有重要益处,但我们建议省略基于患病率的候选协变量的经验性识别。

相似文献

1
On the role of marginal confounder prevalence - implications for the high-dimensional propensity score algorithm.论边缘混杂因素患病率的作用——对高维倾向评分算法的影响
Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):1004-7. doi: 10.1002/pds.3773. Epub 2015 Apr 10.
2
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.使用医疗保健理赔数据进行治疗效果研究中的高维倾向得分调整
Epidemiology. 2009 Jul;20(4):512-22. doi: 10.1097/EDE.0b013e3181a663cc.
3
Machine learning for improving high-dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature.机器学习在改善医疗数据库研究中高维代理混杂因素调整中的应用:当前文献综述。
Pharmacoepidemiol Drug Saf. 2022 Sep;31(9):932-943. doi: 10.1002/pds.5500. Epub 2022 Jul 5.
4
Regularized Regression Versus the High-Dimensional Propensity Score for Confounding Adjustment in Secondary Database Analyses.二次数据库分析中用于混杂因素调整的正则化回归与高维倾向评分比较
Am J Epidemiol. 2015 Oct 1;182(7):651-9. doi: 10.1093/aje/kwv108. Epub 2015 Aug 1.
5
Comparing the high-dimensional propensity score for use with administrative data with propensity scores derived from high-quality clinical data.比较使用行政数据的高维倾向评分与从高质量临床数据得出的倾向评分。
Stat Methods Med Res. 2020 Feb;29(2):568-588. doi: 10.1177/0962280219842362. Epub 2019 Apr 11.
6
[Application of disease-risk score in pharmacoepidemiologic studies].疾病风险评分在药物流行病学研究中的应用
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Feb 10;38(2):261-266. doi: 10.3760/cma.j.issn.0254-6450.2017.02.025.
7
A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases.利用大型医疗保健数据库估计因果效应的混杂因素选择和调整方法比较。
Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):424-433. doi: 10.1002/pds.5403. Epub 2022 Jan 7.
8
Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples.在小样本中进行高维倾向评分分析治疗效果时的协变量选择。
Am J Epidemiol. 2011 Jun 15;173(12):1404-13. doi: 10.1093/aje/kwr001. Epub 2011 May 20.
9
Studies with many covariates and few outcomes: selecting covariates and implementing propensity-score-based confounding adjustments.具有众多协变量和较少结局的研究:选择协变量并实施基于倾向评分的混杂调整。
Epidemiology. 2014 Mar;25(2):268-78. doi: 10.1097/EDE.0000000000000069.
10
Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting.高维倾向评分分析的透明度:诊断和报告指南。
Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):411-423. doi: 10.1002/pds.5412. Epub 2022 Feb 12.

引用本文的文献

1
Application of High-Dimensional Propensity Score Methods to the National Health and Aging Trends Study.高维倾向评分方法在国家健康与老龄化趋势研究中的应用。
J Gerontol A Biol Sci Med Sci. 2024 Sep 1;79(9). doi: 10.1093/gerona/glae178.
2
High-dimensional propensity scores for empirical covariate selection in secondary database studies: Planning, implementation, and reporting.高维倾向得分在二次数据库研究中对经验协变量选择的应用:规划、实施和报告。
Pharmacoepidemiol Drug Saf. 2023 Feb;32(2):93-106. doi: 10.1002/pds.5566. Epub 2022 Nov 22.
3
Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting.

本文引用的文献

1
High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions.高维倾向评分算法在具有时变干预措施的比较效果研究中的应用
Stat Med. 2015 Feb 28;34(5):753-81. doi: 10.1002/sim.6377. Epub 2014 Dec 8.
2
CNODES: the Canadian Network for Observational Drug Effect Studies.CNODES:加拿大药物效应观察研究网络。
Open Med. 2012 Oct 30;6(4):e134-40. Print 2012.
3
High-dimensional versus conventional propensity scores in a comparative effectiveness study of coxibs and reduced upper gastrointestinal complications.
高维倾向评分分析的透明度:诊断和报告指南。
Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):411-423. doi: 10.1002/pds.5412. Epub 2022 Feb 12.
4
A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases.利用大型医疗保健数据库估计因果效应的混杂因素选择和调整方法比较。
Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):424-433. doi: 10.1002/pds.5403. Epub 2022 Jan 7.
5
Reported evidence on the effectiveness of mass media interventions in increasing knowledge and use of family planning in low and middle-income countries: a systematic mixed methods review.报道称,大众媒体干预在提高中低收入国家计划生育知识和使用方面的有效性的证据:系统的混合方法综述。
J Glob Health. 2019 Dec;9(2):020420. doi: 10.7189/jogh.09.020420.
6
Building a framework for the evaluation of knowledge translation for the Canadian Network for Observational Drug Effect Studies.为加拿大观察性药物效应研究网络的知识转化评估构建框架。
Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1(Suppl 1):8-25. doi: 10.1002/pds.4738. Epub 2019 Feb 20.
7
Automated data-adaptive analytics for electronic healthcare data to study causal treatment effects.用于研究因果治疗效果的电子医疗数据的自动化数据自适应分析。
Clin Epidemiol. 2018 Jul 6;10:771-788. doi: 10.2147/CLEP.S166545. eCollection 2018.
8
Propensity Scores in Pharmacoepidemiology: Beyond the Horizon.药物流行病学中的倾向评分:超越地平线。
Curr Epidemiol Rep. 2017 Dec;4(4):271-280. doi: 10.1007/s40471-017-0131-y. Epub 2017 Nov 6.
高维与传统倾向评分在 Coxibs 与减少上消化道并发症的比较有效性研究中的应用。
Eur J Clin Pharmacol. 2013 Mar;69(3):549-57. doi: 10.1007/s00228-012-1334-2. Epub 2012 Jul 5.
4
Confronting "confounding by health system use" in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment.直面医疗保险计划 D 中的“医疗体系使用偏倚”:倾向评分法在混杂调整中的比较效果。
Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2(Suppl 2):90-8. doi: 10.1002/pds.3250.
5
Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records.通过半自动化高维倾向评分算法进行混杂调整:在电子病历中的应用。
Pharmacoepidemiol Drug Saf. 2011 Aug;20(8):849-57. doi: 10.1002/pds.2152. Epub 2011 Jun 30.
6
Bias formulas for sensitivity analysis of unmeasured confounding for general outcomes, treatments, and confounders.用于一般结局、处理和混杂因素的未测量混杂敏感性分析的偏倚公式。
Epidemiology. 2011 Jan;22(1):42-52. doi: 10.1097/EDE.0b013e3181f74493.
7
Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases.多变量调整的药物流行病学分析,使用来自多个医疗保健利用数据库的机密信息进行汇总。
Pharmacoepidemiol Drug Saf. 2010 Aug;19(8):848-57. doi: 10.1002/pds.1867.
8
High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.使用医疗保健理赔数据进行治疗效果研究中的高维倾向得分调整
Epidemiology. 2009 Jul;20(4):512-22. doi: 10.1097/EDE.0b013e3181a663cc.
9
Bias formulas for external adjustment and sensitivity analysis of unmeasured confounders.未测量混杂因素的外部调整和敏感性分析的偏倚公式。
Ann Epidemiol. 2008 Aug;18(8):637-46. doi: 10.1016/j.annepidem.2008.04.003.
10
Spurious effects from an extraneous variable.来自外部变量的虚假效应。
J Chronic Dis. 1966 Jun;19(6):637-47. doi: 10.1016/0021-9681(66)90062-2.